A detailed history of D. E. Shaw & Co., Inc. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 7,920 shares of WST stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,920
Holding current value
$2.62 Million
% of portfolio
0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$277.16 - $333.3 $2.03 Million - $2.44 Million
-7,322 Reduced 48.04%
7,920 $2.38 Million
Q2 2024

Aug 14, 2024

SELL
$314.68 - $395.94 $3.02 Million - $3.8 Million
-9,604 Reduced 38.65%
15,242 $5.02 Million
Q1 2024

May 15, 2024

SELL
$338.27 - $413.0 $1.42 Million - $1.73 Million
-4,198 Reduced 14.45%
24,846 $9.83 Million
Q4 2023

Feb 14, 2024

BUY
$318.29 - $392.21 $9.24 Million - $11.4 Million
29,044 New
29,044 $10.2 Million
Q2 2023

Aug 14, 2023

BUY
$334.63 - $382.47 $2.47 Million - $2.82 Million
7,370 Added 653.37%
8,498 $3.25 Million
Q1 2023

May 15, 2023

SELL
$232.5 - $346.47 $2.52 Million - $3.76 Million
-10,843 Reduced 90.58%
1,128 $390,000
Q4 2022

Feb 14, 2023

SELL
$209.34 - $261.61 $9.24 Million - $11.6 Million
-44,155 Reduced 78.67%
11,971 $2.82 Million
Q3 2022

Nov 14, 2022

SELL
$246.08 - $343.65 $6.86 Million - $9.58 Million
-27,887 Reduced 33.19%
56,126 $13.8 Million
Q2 2022

Aug 15, 2022

BUY
$280.61 - $420.45 $23.2 Million - $34.8 Million
82,789 Added 6763.81%
84,013 $25.4 Million
Q1 2022

May 16, 2022

BUY
$357.49 - $445.92 $204,126 - $254,620
571 Added 87.44%
1,224 $503,000
Q4 2021

Feb 14, 2022

BUY
$402.25 - $471.34 $262,669 - $307,785
653 New
653 $306,000
Q1 2021

May 17, 2021

SELL
$257.29 - $307.53 $261,406 - $312,450
-1,016 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$261.16 - $301.66 $235,044 - $271,494
-900 Reduced 46.97%
1,016 $288,000
Q3 2020

Nov 16, 2020

SELL
$224.99 - $288.02 $549,200 - $703,056
-2,441 Reduced 56.02%
1,916 $527,000
Q2 2020

Aug 14, 2020

SELL
$149.8 - $227.17 $1.24 Million - $1.87 Million
-8,250 Reduced 65.44%
4,357 $990,000
Q1 2020

May 15, 2020

SELL
$128.96 - $174.76 $1.79 Million - $2.42 Million
-13,848 Reduced 52.35%
12,607 $1.92 Million
Q4 2019

Feb 14, 2020

SELL
$137.6 - $151.21 $5.84 Million - $6.41 Million
-42,414 Reduced 61.59%
26,455 $3.98 Million
Q3 2019

Nov 14, 2019

BUY
$121.41 - $150.02 $2.77 Million - $3.42 Million
22,789 Added 49.46%
68,869 $9.77 Million
Q2 2019

Aug 14, 2019

SELL
$111.27 - $125.15 $411,476 - $462,804
-3,698 Reduced 7.43%
46,080 $5.77 Million
Q1 2019

May 15, 2019

BUY
$94.53 - $110.2 $4.71 Million - $5.49 Million
49,778 New
49,778 $5.49 Million
Q4 2018

Feb 14, 2019

SELL
$93.0 - $123.98 $565,812 - $754,294
-6,084 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$98.01 - $123.47 $301,086 - $379,299
-3,072 Reduced 33.55%
6,084 $751,000
Q2 2018

Aug 14, 2018

SELL
$83.32 - $101.88 $608,819 - $744,437
-7,307 Reduced 44.38%
9,156 $909,000
Q1 2018

May 15, 2018

SELL
$85.56 - $102.4 $655,988 - $785,100
-7,667 Reduced 31.77%
16,463 $1.45 Million
Q4 2017

Feb 14, 2018

BUY
$91.65 - $101.65 $173,585 - $192,525
1,894 Added 8.52%
24,130 $2.38 Million
Q3 2017

Nov 14, 2017

BUY
$84.54 - $96.75 $1.88 Million - $2.15 Million
22,236
22,236 $2.14 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.5B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.